Mapping immune responses in people with certain virus-related cancers
Part of Cancer, Digestive system clinical trials.
This study collects blood and/or tumor-related samples to map how your immune system recognizes cancer. It aims to better understand immune targets and immune cell types, which may help guide future cancer treatments for certain virus-related cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have one of these cancers: EBV-related cancer, HPV-related cancer, or (in certain cases) liver cancer with high AFP.
- If you have head and neck squamous cell cancer, your tumor must be HPV-positive (p16-positive is accepted).
- If you have cancer of the cervix, vulva, or anal canal, you do not need HPV positivity, but you must meet the study’s sample rules.
- You must agree in writing to participate after learning the study details.
- A study doctor must feel your health and your collected samples can be safely used and interpreted.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what makes some cancers more “noticeable” to the immune system. It may help researchers design better future immunotherapy by collecting information (often including blood samples) from people with different cancers.
This study collects and analyzes tumor tissue to learn what drives certain cancers and growths linked to viruses, HIV, and immune system problems. Results may help researchers understand disease causes and point to better future treatments.
This study collects tissue and blood samples from people who have or have been exposed to certain viruses (HIV, KSHV, HPV, EBV, or HTLV-1) or who have developed cancer or precancerous skin lesions. The samples help researchers understand how these viruses may lead to cancer.
This study looks at tumor samples from people with certain cancers to compare those caused by viruses (like HPV, HIV, or EBV) with those not caused by viruses. The goal is to understand why some tumors respond differently to treatments, which may help improve future treatment approaches.
This study looks at how your immune system and cancer cells interact. It may help doctors understand your cancer better and could lead to new treatments.
This study looks at how viruses like HPV, HIV, and EBV affect the tumor environment and why some cancers become resistant to treatment. It aims to understand these mechanisms to improve future treatments.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.